Clinical Trial Search

Primary: Reproductive Life Goal Behavioral Intentions — 3.6; 2.7; 3.3; 3.0 score on scale

Primary: Changes in Frequency of Unprotected Intercourse (Youth) — 1.42; 1.16; 1.38 number of occassions — p=<.05

Primary: Number of Participants With a 50% Decrease in Hot Flash Score — 50; 53 Participants

Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05

Primary: Hot Flash Frequency — 2.2; 1.4 daily hot flashes

Primary: Contraception Use Self-efficacy Scale Score (Aim 1b) — 23.2; 22.45; 25.22; 23.04 Scores on a scale — p=0.011

Primary: Occurrence of Reproductive Needs Discussion With Shared Decision Making (SDM) — 29; 20; 139; 119 Participants — p=0.31

Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants

Primary: Feasibility of Providing Intervention — 25; 22 Participants

Primary: Change in Sexual and Reproductive Health and Rights Knowledge Survey Score — 0.45; 0.44; 0.47; 0.49 score on a scale

Primary: Current Use of Highly Effective Contraception — 2; 17 Participants

Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0

Primary: Number of Participants With Any Healthcare Utilization From Baseline to 6 Months — 9; 7 Participants

Primary: Identify and Utilization of Primary Care Provider (PCP) — 426; 114; 771 Participants — p=0.624

Primary: Change in the Average LH Pulse Amplitude — -.04; .4 IU/L

Primary: USPE Scale Scores — 3.73; 3.63; 1.85; 2.02 score on a scale

Primary: Intention to Initiate Contraception — 59 Participants

Primary: Mean Beck Depression Inventory Score — 1.4; 1; 1.1 Units on a scale

Primary: Change in Frequency of Recent Dual Method Use — 3.17; 3.45 score on a scale — p=.177

Primary: Implementation Fidelity: Conducting Condom Line-up — 1.67; 1.26 score on an item

Primary: Changes in Luteinizing Hormone (LH) Pulse Amplitude (Aim 1) — 4.1; 3.6 IU/L

Primary: Feasibility of Integrating Point-of-care Testing (Monitoring & Evaluation Indicators) — 396; 378; 399; 216 Participants

Primary: Utilization of Postpartum Contraception — 199; 213 participants — p=<0.05

Primary: Use of a Effective Contraceptive Method at Four-months Post-abortion — 135; 101 participants

Primary: Difference Between Peak Inhibin B — 100.8; 38.8 picograms/mL

Primary: Abstinence Attitudes — 4.18; 4.17; 4.17; 4.26 score on a scale

Primary: Ovulation in Cycle 2 — 3; 2 Participants

Primary: Number of Non-pregnant Couples With Modern Contraceptive Use in Past 3 Months — 265; 295 Couple

Primary: Percent of Participants With Pregnancy Risk — 11.8; 11.1; 10.2; 10.8 percentage of participants — p=0.6430

Primary: Shared Decision-making About Contraceptive Methods — 165; 272; 222; 190 Participants — p=0.80